Intratumoral IL-7 delivery by mesenchymal stromal cells potentiates IFNgamma-transduced tumor cell immunotherapy of experimental glioma.
about
Mesenchymal stem cells secretome as a modulator of the neurogenic niche: basic insights and therapeutic opportunitiesMesenchymal stem cells as a vector for the inflammatory prostate microenvironmentImmunotherapeutic organoids: a new approach to cancer treatmentToward brain tumor gene therapy using multipotent mesenchymal stromal cell vectors.Mesenchymal stem cells at the intersection of cell and gene therapy.Specific chemotaxis of magnetically labeled mesenchymal stem cells: implications for MRI of gliomaMesenchymal stem cells engineered for cancer therapyStrategies in gene therapy for glioblastoma.Non-hematopoietic stem cells as factories for in vivo therapeutic protein production.Clinical applications of mesenchymal stem cellsEngineering antiphagocytic biomimetic drug carriers.Advances in stem cells, induced pluripotent stem cells, and engineered cells: delivery vehicles for anti-glioma therapy.The future of glioblastoma therapy: synergism of standard of care and immunotherapy.Use of genetically engineered stem cells for glioma therapy.Mesenchymal stem cell-mediated cancer therapy: A dual-targeted strategy of personalized medicine.Inhibitory effect of genetically engineered mesenchymal stem cells with Apoptin on hepatoma cells in vitro and in vivo.Mesenchymal stem cells as therapeutic agents and in gene delivery for the treatment of glioma*.Low-dose irradiated mesenchymal stromal cells break tumor defensive properties in vivo.Current status and potential challenges of mesenchymal stem cell-based therapy for malignant gliomas
P2860
Q26799013-43E78EA1-B40C-4D22-B9CE-88693CE4030DQ26853374-25BDFB01-A74C-45DE-8D86-4E31D7E0A416Q26853431-354482B5-E733-410B-8A9C-3E8C7C788C29Q33560685-299BD9AD-C34F-48DD-BDD6-29F9D3CB08BFQ34676808-E5B80889-BAAB-468A-9F5E-D6611F7B60DDQ36071865-B835AAC6-621B-4ADA-A7E6-53BE4D869FB7Q36092724-B757A519-9D27-461F-8A6F-76F183F6F9BEQ37420576-21DEC3BE-1D12-4F5F-8891-D3B19BEFB67EQ37874445-7FADA46A-44A5-4876-A213-30FB6081720DQ38122364-F1DB7EE4-DBB4-4B28-A03A-B62046924286Q38123856-F4B6C575-5292-4225-AF2C-FBE2380179FFQ38227489-803F9659-43B2-4581-9202-68B016867F04Q38255481-C7402428-6C66-4BC6-A4CB-6555FBF1D787Q38730790-D5B88ED4-43D9-409A-A4C8-6377FB762806Q39863924-3782767A-3F79-4288-917B-552247DC0776Q40770609-E6AFD7C7-B07D-47F1-AAA9-D5BFF8F206CBQ47109590-F81868FA-E633-4EC4-9BDF-09FB2B6F69C4Q55457117-5D264EB0-07D4-4A75-AC0E-134BCD60A9E3Q58707289-EA6003FD-7692-44D0-9EB8-5D9264FEBBF9
P2860
Intratumoral IL-7 delivery by mesenchymal stromal cells potentiates IFNgamma-transduced tumor cell immunotherapy of experimental glioma.
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Intratumoral IL-7 delivery by ...... herapy of experimental glioma.
@ast
Intratumoral IL-7 delivery by ...... herapy of experimental glioma.
@en
type
label
Intratumoral IL-7 delivery by ...... herapy of experimental glioma.
@ast
Intratumoral IL-7 delivery by ...... herapy of experimental glioma.
@en
prefLabel
Intratumoral IL-7 delivery by ...... herapy of experimental glioma.
@ast
Intratumoral IL-7 delivery by ...... herapy of experimental glioma.
@en
P2093
P1476
Intratumoral IL-7 delivery by ...... herapy of experimental glioma.
@en
P2093
Andreas Svensson
Anna Darabi
Daniel Bexell
Peter Siesjö
Salina Gunnarsson
P304
P356
10.1016/J.JNEUROIM.2009.10.017
P577
2009-11-14T00:00:00Z